Description
+ Include: 41 videos + 34 pdfs, size: 24 GB
+ Target Audience: surgical oncologists, gastroenterologists, internal medicine specialists, pathologists
+ Sample video: contact me for sample video
+ Information:
Friday, November 18, 2022, 7:00 AM – Saturday, November 19, 2022, 1:15 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
The incidence of pancreas cancer continues to rise, and related morbidity and mortality remain unacceptably high. Treatment approaches continue to evolve with better insights into disease pathogenesis and progression.
This day and a half long, in-person symposium is a combined effort of MSK’s Hepatopancreatobiliary Disease Management Team (HPB DMT) and Center for Pancreatic Cancer Research (CPCR) and will provide a comprehensive review of the epidemiology, genomic, and immunologic features of pancreatic adenocarcinoma and how advances in these areas are impacting current management.
The program will include an emphasis on contemporary management approaches in patients with resectable and unresectable disease, the respective roles of and outcomes of chemotherapy (adjuvant/neoadjuvant/palliative) and radiation therapy (standard/ablative), and a discussion of novel and emerging therapies, including immunotherapy, vaccines, and genomic-directed therapies. Didactic sessions will be supplemented with several case presentations with audience participation. We will also feature a presentation from one of our patients recently treated for pancreas cancer.
Who Should Attend*
This symposium is intended for medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, supportive care staff, advanced practice practitioners, nurses, trainees, and other disciplines.
- Update the genetic and molecular hallmarks of pancreas cancer
- Outline current diagnostic approaches in patients with pancreas cancer
- Describe contemporary surgical strategies, including the role of vascular reconstruction
- Review contemporary non-surgical therapies in the adjuvant, neoadjuvant and palliative settings
- Define novel and emerging therapies
+ Topics:
A Worldwide Snapshot of Pancreas Cancer Care.mp4
A Worldwide Snapshot of Pancreas Cancer Care.pdf
Ablative Radiation Therapy.mp4
Ablative Radiation Therapy.pdf
BIOLOGY EPIDEMIOLOGY Q&A.mp4
Changing Epidemiology of Pancreas Cancer.mp4
Changing Epidemiology of Pancreas Cancer.pdf
CHEMOTHERAPY RADIATION THERAPY Q&A.mp4
Day 1 – CASE PRESENTATIONS.mp4
Day 2 – CASE PRESENTATIONS.mp4
DEBATE- (CHEMOTHERAPY) Neoadjuvant Chemotherapy vs. Upfront Resection in Patients with Resectable Disease.mp4
DEBATE- (CHEMOTHERAPY) Neoadjuvant Chemotherapy vs. Upfront Resection in Patients with Resectable Disease.pdf
DEBATE- (NO) Surgery in Patients with Stage IV Disease- Is There Ever a Role..mp4
DEBATE- (NO) Surgery in Patients with Stage IV Disease- Is There Ever a Role..pdf
DEBATE- (RESECTION) Neoadjuvant Chemotherapy vs. Upfront Resection in Patients with Resectable Disease.mp4
DEBATE- (RESECTION) Neoadjuvant Chemotherapy vs. Upfront Resection in Patients with Resectable Disease.pdf
DEBATE- (YES) Surgery in Patients with Stage IV Disease- Is There Ever a Role..mp4
DEBATE- (YES) Surgery in Patients with Stage IV Disease- Is There Ever a Role..pdf
DIAGNOSIS IMAGING STAGING Q&A.mp4
Endoscopic Approaches.mp4
Endoscopic Approaches.pdf
Genetic Risk Assessment and Early Detection of Pancreatic Cancer- Looking Ahead to 2023.mp4
Genetic Risk Assessment and Early Detection of Pancreatic Cancer- Looking Ahead to 2023.pdf
Genomic Directed Therapies.mp4
Genomic Directed Therapies.pdf
Initial Assessment General Considerations.mp4
Initial Assessment General Considerations.pdf
Is There a Role for PET in Assession PDAC..mp4
Is There a Role for PET in Assession PDAC..pdf
Managing The Bile Duct and Gallbladder in Patients with Unresectable Disease.mp4
Managing The Bile Duct and Gallbladder in Patients with Unresectable Disease.pdf
NOVEL TREATMENT APPROACHES Q&A.mp4
Optimal Imaging of PDAC.mp4
Optimal Imaging of PDAC.pdf
Pancreas Center Highlights.mp4
Pancreas Center Highlights.pdf
Pancreas2022_Brochure.pdf
PATIENT PRESENTATION.mp4
Patient Selection.mp4
Patient Selection.pdf
PDAC Genomics.mp4
PDAC Genomics.pdf
PDAC Immunology.mp4
PDAC Immunology.pdf
PDAC SURGICAL APPROACHES Q&A.mp4
Robotic Distal Pancreatectomy.mp4
Robotic Distal Pancreatectomy.pdf
Robotic Whipple.mp4
Robotic Whipple.pdf
Role of Microbiome in PDAC Oncogenesis.mp4
Role of Microbiome in PDAC Oncogenesis.pdf
Role of Radiation Therapy- Adjuvant, Neoadjuvant, Palliative.mp4
Role of Radiation Therapy- Adjuvant, Neoadjuvant, Palliative.pdf
Role of Vascular Resection.mp4
Role of Vascular Resection.pdf
Screening High Risk Patients.mp4
Screening High Risk Patients.pdf
Targeting KRAS.mp4
Targeting KRAS.pdf
Treating Complications After Pancreas Resection.mp4
Treating Complications After Pancreas Resection.pdf
Treating Patients with Locally Advanced Disease.mp4
Treating Patients with Locally Advanced Disease.pdf
Treating Patients with Metastatic Disease.mp4
Treating Patients with Metastatic Disease.pdf
Upcoming Clinical Trials.mp4
Upcoming Clinical Trials.pdf
Update on cfDNA.mp4
Update on cfDNA.pdf
Update on Chemotherapy- Adjuvant and Neoadjuvant.mp4
Update on Chemotherapy- Adjuvant and Neoadjuvant.pdf
Vaccine Trial.mp4
Vaccine Trial.pdf
Vascular Resections.mp4
Vascular Resections.pdf
Reviews
There are no reviews yet.